| 1 |
21116607 | Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. | 2011 Mar |
2 |
| 2 |
20628086 | Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. | 2010 Oct |
1 |
| 3 |
18376358 | Rosiglitazone in the prevention of diabetes and cardiovascular disease: dream or reality? | 2008 Apr |
2 |
| 4 |
17354538 | [The DREAM of diabetes prevention]. | 2007 Jan 17 |
1 |
| 5 |
17684471 | Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial. | 2007 Spring |
1 |
| 6 |
18035959 | Prevention of Type 2 diabetes: fact or fiction? | 2007 Dec |
1 |
| 7 |
19804301 | Rosiglitazone: a disappointing DREAM. | 2007 Sep |
1 |
| 8 |
17209507 | [DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease]. | 2006 Oct |
1 |
| 9 |
15322749 | Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. | 2004 Sep |
1 |
| 10 |
15628822 | Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinediones. | 2004 Oct |
1 |
| 11 |
12324991 | Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE. | 2002 Sep-Oct |
1 |